This week we’ve highlighted a medical battery that can be implemented without surgery and a new COVID-19 vaccine. We also look at enrollment challenges in clinical trials as well as a report on diversity in trial populations. Finally, we highlight a major acquisition in the medtech sector. Each week we ... READ MORE >
biotech
5 things to know in life sciences: Week of Oct. 31
This week we’ve highlighted the RSV vaccine race, J.P. Morgan’s private equity life sciences investment, a new product promoting decentralized oncology trials, the shocking expected cost of gene therapies, and Moderna’s revised earnings forecast amid falling COVID-19 cases. Each week we highlight five ... READ MORE >
5 things to know in life sciences: Week of Sept. 12
This week, we look at a new executive order encouraging biomanufacturing, a rare company going public through a special purpose acquisition company and what an executive can do when a trial is placed on a clinical hold. We also look at how progress in curing hepatitis C remains slow despite revolutionary ... READ MORE >
5 things to know in life sciences: Week of July 18, 2022
This week we highlight continued investment in driving more diversity and better representation in clinical trials. We also look at the impact of decentralized technology on trial enrollments, a major whistleblower settlement and the approval of a COVID-19 vaccine manufactured using traditional methods. ... READ MORE >
5 things to know in life sciences: Week of July 11, 2022
This week we highlight innovative treatments for heart disease and depression. We also look at a decision by the Food and Drug Administration to allow pharmacists to prescribe a COVID-19 drug, as well as the use of artificial intelligence in the fight against ALS. Finally, we touch on Vertex’s acquisition ... READ MORE >
5 things to know in life sciences: Week of June 27, 2022
This week we highlight actions by a U.S. Food and Drug Administration advisory panel deciding on what COVID-19 boosters should contain for this fall. The panel voted overwhelmingly to include updates for the omicron variant, setting up the potential that COVID-19 vaccines will be managed like the flu with ... READ MORE >
5 things to know in life sciences: Week of June 13, 2022
Diagnosing some disorders in children present unique challenges. Now, companies are looking at using artificial intelligence to uncover subtle tools to help. We also look at a new report on diversity in the biotech industry, research into long COVID-19, and Food and Drug Administration site inspections. ... READ MORE >
5 things to know in life sciences: Week of May 23, 2022
This week we highlight an international collaboration for an innovative under-the-skin insulin delivery device, a focus on improving diversity for clinical trials and a promising COVID-19 vaccine for children under 5. Finally, at-home testing for sexually transmitted diseases is coming, and the University ... READ MORE >
5 things to know in life sciences: Week of May 9, 2022
This week we highlight a promising application that leverages artificial intelligence to scan biopsies to help guide cancer treatments. We also look at a novel approach using music to treat multiple sclerosis, a new report that indicates new COVID-19 strains are starting to show a predictable pattern, and ... READ MORE >
5 things to know in life sciences: Week of May 2, 2022
This week we highlight a series of moves by the Food and Drug Administration related to COVID-19 treatments, Alzheimer's and CBD. We also look at contract research organizations and a robotics manufacturing partnership in cell and gene therapy, as well as sentiment in the biotech funding space. Each week ... READ MORE >